Th17 cells play a critical role in the pathogenesis of SLE and several evidences have confirmed that refining the balance of CD4+Treg/Th17 cells could benefit from reducing disease activity (32, 64). The gene discussed is CD4; the disease is systemic lupus erythematosus.